









Mercado
/
Acciones
/
nasdaq-bax
/

Baxter International Inc

BAX

16.670USD

-0.450-2.63%

Cierre 03/26, 16:00（ET）Cotizaciones retrasadas 15 min

9.24BCap. mercado

PérdidaP/E TTM



Baxter International Inc

16.670

-0.450-2.63%

Descripción general Finanzas Análisis Compañía

Descripción general

Finanzas

Análisis

Compañía

Más Datos de Baxter International Inc Compañía

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.

Información de Baxter International Inc



Símbolo de cotizaciónBAX

Nombre de la empresaBaxter International Inc

Fecha de salida a bolsaJun 20, 2097

Director ejecutivoHider (Andrew P)

Número de empleados38000

Tipo de seguridadOrdinary Share

Fin del año fiscalJun 20

DirecciónOne Baxter Parkway

CiudadDEERFIELD

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísUnited States of America

Código postal60015

Teléfono12249482000

Sitio Webhttps://www.baxter.com/

Símbolo de cotizaciónBAX

Fecha de salida a bolsaJun 20, 2097

Director ejecutivoHider (Andrew P)

Ejecutivos de Baxter International Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Andrew P. Hider

President, Chief Executive Officer, Director

569.85K

+35.41%

Dr. Jeanne K. Mason, Ph.D.

Chief Human Resources Officer, Executive Vice President

141.02K

-0.46%

Mr. David S. Rosenbloom

Executive Vice President, General Counsel

132.18K

-6.02%

Mr. Reazur Rasul

Executive Vice President, Group President - Healthcare Systems and Technologies

120.28K

-11.88%

Dr. Stephen N. (Steve) Oesterle, M.D.

Independent Director

35.70K

+20.12%

Ms. Catherine R. (Cathy) Smith

Independent Director

30.23K

+23.76%

Ms. Patricia B. (Patty) Morrison

Independent Director

22.94K

+31.31%

Mr. Stephen H. (Steve) Rusckowski

Independent Director

16.45K

+43.66%

Mr. Jeffrey A. (Jay) Craig

Independent Director

10.65K

+67.41%

Ms. Nancy M. Schlichting

Lead Independent Director

7.97K

+90.13%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Andrew P. Hider

President, Chief Executive Officer, Director

569.85K

+35.41%

Dr. Jeanne K. Mason, Ph.D.

Chief Human Resources Officer, Executive Vice President

141.02K

-0.46%

Mr. David S. Rosenbloom

Executive Vice President, General Counsel

132.18K

-6.02%

Mr. Reazur Rasul

Executive Vice President, Group President - Healthcare Systems and Technologies

120.28K

-11.88%

Dr. Stephen N. (Steve) Oesterle, M.D.

Independent Director

35.70K

+20.12%

Ms. Catherine R. (Cathy) Smith

Independent Director

30.23K

+23.76%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

Infusion Therapies and Technologies

1.02B

36.44%

Care and Connectivity Solutions

474.00M

16.87%

Injectables and Anesthesia

332.00M

11.81%

Advanced Surgery

296.00M

10.53%

Front Line Care

293.00M

10.43%

Otro

391.00M

13.91%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

1.54B

54.66%

International

1.27B

45.34%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Infusion Therapies and Technologies

1.02B

36.44%

Care and Connectivity Solutions

474.00M

16.87%

Injectables and Anesthesia

332.00M

11.81%

Advanced Surgery

296.00M

10.53%

Front Line Care

293.00M

10.43%

Otro

391.00M

13.91%

Estadísticas de accionistas

Actualizado: jue., 19 de feb

Accionistas

Tipos de accionistas

Accionistas

Proporción

Pzena Investment Management, LLC

13.57%

The Vanguard Group, Inc.

12.07%

Dodge & Cox

11.04%

BlackRock Institutional Trust Company, N.A.

6.31%

BlackRock Financial Management, Inc.

5.88%

Otro

51.12%

Accionistas

Proporción

Pzena Investment Management, LLC

13.57%

The Vanguard Group, Inc.

12.07%

Dodge & Cox

11.04%

BlackRock Institutional Trust Company, N.A.

6.31%

BlackRock Financial Management, Inc.

5.88%

Otro

51.12%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor/Hedge Fund

51.98%

Investment Advisor

47.94%

Insurance Company

5.13%

Research Firm

2.48%

Hedge Fund

2.09%

Pension Fund

1.43%

Sovereign Wealth Fund

1.24%

Bank and Trust

1.07%

Individual Investor

0.52%

Participación institucional



Actualizado: lun., 8 de dic

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

1743

527.76M

108.76%

+72.60K

2025Q3

1826

527.84M

110.04%

+1.85M

2025Q2

1880

509.50M

105.73%

+4.72M

2025Q1

1916

504.93M

105.92%

-38.38M

2024Q4

1965

494.73M

105.04%

+14.02M

2024Q3

1980

482.92M

103.29%

+12.67M

2024Q2

2019

470.33M

102.19%

-1.85M

2024Q1

2069

469.00M

102.47%

-52.95M

2023Q4

2111

469.21M

101.33%

+9.34M

2023Q3

2090

463.57M

98.58%

+5.62M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Pzena Investment Management, LLC

57.39M

11.16%

+1.93M

+3.48%

Sep 30, 2025

The Vanguard Group, Inc.

62.26M

12.11%

+305.92K

+0.49%

Sep 30, 2025

Dodge & Cox

57.40M

11.17%

+5.27M

+10.12%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

31.32M

6.09%

+1.48M

+4.95%

Sep 30, 2025

BlackRock Financial Management, Inc.

24.69M

4.8%

+5.96M

+31.81%

Sep 30, 2025

Fidelity Management & Research Company LLC

11.93M

2.32%

+7.96M

+200.31%

Sep 30, 2025

State Street Investment Management (US)

22.00M

4.28%

+60.06K

+0.27%

Sep 30, 2025

Geode Capital Management, L.L.C.

12.54M

2.44%

-345.65K

-2.68%

Sep 30, 2025

Greenhaven Associates, Inc.

10.69M

2.08%

+4.40M

+70.05%

Dec 31, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

iShares Large Cap Value Active ETF

2.23%

First Trust Indxx Medical Devices ETF

1.69%

Invesco Raymond James SB-1 Equity ETF

1.5%

State Street SPDR S&P Health Care Equipment ETF

1.37%

Invesco S&P 500 Equal Weight Health Care ETF

1.26%

Franklin US Dividend Booster Index ETF

1.26%

iShares U.S. Medical Devices ETF

1.13%

Invesco Zacks Multi-Asset Income ETF

0.8%

Humankind US Stock ETF

0.76%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

0.57%

iShares Large Cap Value Active ETF

Proporción2.23%

First Trust Indxx Medical Devices ETF

Proporción1.69%

Invesco Raymond James SB-1 Equity ETF

Proporción1.5%

State Street SPDR S&P Health Care Equipment ETF

Proporción1.37%

Invesco S&P 500 Equal Weight Health Care ETF

Proporción1.26%

Franklin US Dividend Booster Index ETF

Proporción1.26%

iShares U.S. Medical Devices ETF

Proporción1.13%

Invesco Zacks Multi-Asset Income ETF

Proporción0.8%

Humankind US Stock ETF

Proporción0.76%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

Proporción0.57%

Dividendos



Un total de 2.28B USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Feb 12, 2026

BAX.NB Final Cash Dividend of gross USD 0.01 paid on Apr 01, 2026 going ex on Feb 27, 2026

Feb 27, 2026

Apr 01, 2026

Feb 27, 2026

Feb 12, 2026

BAX.NB Interim Cash Dividend of gross USD 0.01 paid on Apr 01, 2026 going ex on Feb 27, 2026 with reinvestment option

Feb 27, 2026

Apr 01, 2026

Feb 27, 2026

Nov 11, 2025

BAX.NB Final Cash Dividend of gross USD 0.01 paid on Jan 02, 2026 going ex on Nov 28, 2025 with reinvestment option

Nov 28, 2025

Jan 02, 2026

Nov 28, 2025

Jul 14, 2025

BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Oct 01, 2025 going ex on Aug 29, 2025 with reinvestment option

Aug 29, 2025

Oct 01, 2025

Aug 29, 2025

May 06, 2025

BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Jul 01, 2025 going ex on May 30, 2025 with reinvestment option

May 30, 2025

Jul 01, 2025

May 30, 2025

Feb 11, 2025

BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option

Feb 28, 2025

Apr 01, 2025

Feb 28, 2025

Nov 11, 2024

BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option

Nov 29, 2024

Jan 02, 2025

Nov 29, 2024

Jul 16, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option

Aug 30, 2024

Oct 01, 2024

Aug 30, 2024

May 07, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option

May 31, 2024

Jul 01, 2024

May 31, 2024

Feb 12, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option

Mar 01, 2024

Apr 01, 2024

Feb 29, 2024

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

